The FDA and NIH recently announced plans to phase out animal testing requirements for some therapies. While organoid and AI ...

Lantern Pharma's Q1 2025 earnings reveal clinical progress, AI commercialization plans, and financial discipline.

Guest blog from Laura Foster, Associate Director for Technology and Innovation at techUK , as part of our ...

The unintentional theme of today’s issue is the struggle for control over how we implement AI in the U.S. On one side, where ...

GE HealthCare (Nasdaq: GEHC) today announced the launch of its CleaRecon DL technology for enhancing CBCT imaging.

Stuart J. Schnitt, MD, discussed how AI enhances cancer diagnoses and the need for professional oversight, ethical clarity, and equitable adoption.

The FDA has said it intends to reduce ... The regulator has published a roadmap (PDF) describing its plan to accelerate the validation and adoption of human-relevant NAMs and said it will now ...

We recently published a list of the 10 Most Popular AI Stocks to Avoid Now. In this article, we are going to take a look at where Recursion Pharmaceuticals, Inc.

Microsoft launches Discovery platform that uses agentic AI to compress years of scientific research into days, transforming R ...

According to John Carrafiell, co-CEO of BGO, a global real estate investment manager, the most significant players are not pulling back but plan to ... adoption will drive AI and data center ...